Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 185.00
-2.00 (-1.07%)
Last updated: Nov 7, 2025, 9:00 AM CST
Daiken Biomedical Revenue
Daiken Biomedical had revenue of 449.33M TWD in the quarter ending September 30, 2025, with 52.81% growth. This brings the company's revenue in the last twelve months to 1.78B, up 42.69% year-over-year. In the year 2024, Daiken Biomedical had annual revenue of 1.36B with 14.45% growth.
Revenue (ttm)
1.78B
Revenue Growth
+42.69%
P/S Ratio
8.56
Revenue / Employee
n/a
Employees
20
Market Cap
15.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.36B | 171.97M | 14.45% |
| Dec 31, 2023 | 1.19B | 305.45M | 34.52% |
| Dec 31, 2022 | 884.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition